ஆஸ்பென் நரம்பியல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஆஸ்பென் நரம்பியல். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஆஸ்பென் நரம்பியல் Today - Breaking & Trending Today

Howard J. Federoff, MD, PhD Appointed Chief Executive Officer of Brooklyn ImmunoTherapeutics, Inc.


Press release content from Business Wire. The AP news staff was not involved in its creation.
Howard J. Federoff, MD, PhD Appointed Chief Executive Officer of Brooklyn ImmunoTherapeutics, Inc.
April 6, 2021 GMT
BROOKLYN, N.Y. (BUSINESS WIRE) Apr 6, 2021
Brooklyn ImmunoTherapeutics, Inc. (NYSE American: BTX) (“Brooklyn” or “the Company”), a biopharmaceutical company focused on exploring the role that cytokine-based therapy can have in treating patients with cancer, today announced the appointment of Howard J. Federoff, M.D., Ph.D., as Chief Executive Officer and President and a director as of 16 April 2021. Dr. Federoff succeeds Ronald Guido who was serving as Interim CEO and will remain on Brooklyn’s management team as Chief Development Officer. ....

New York , United States , San Diego , Charles Cherington , Bioscience Novellus , Nicholas Chang , Howardj Federoff , Ronald Guido , Medgenesis Therapeutix , Neurotherapy Bio , Brooklyn Immunotherapeutics , Development Officer , University Of California , School Of Medicine , Albert Einstein College Of Medicine , Aspen Neuroscience Inc , Harvard Medical School , Advisory Committee , Academic Health Center , Brooklyn Immunotherapeutics Inc , American Association For The Advancement Of Science , Georgetown University , Board Of The Association , National Academy Of Inventors , Health Sciences , Chief Executive Officer ,

Aspen Neuroscience Announces Appointment of Damien McDevitt, PhD as President and Chief Executive Officer


Aspen Neuroscience Announces Appointment of Damien McDevitt, PhD as President and Chief Executive Officer
Company Poised for Next Stage of Growth
News provided by
Share this article
Share this article
SAN DIEGO, Jan. 25, 2021 /PRNewswire/ Aspen Neuroscience, a private biotechnology company developing the first autologous neuron replacement therapy to treat Parkinson s disease, announced today that it has appointed biotech leader Damien McDevitt, PhD, as President and Chief Executive Officer.  Dr. McDevitt will also be joining the company s board of directors.
Damien McDevitt, PhD, President & CEO of Aspen Neuroscience
We are excited to welcome Damien to Aspen Neuroscience at a pivotal moment of growth and development for the company, said Faheem Hasnain, Aspen Board Chairman. His experience leading global teams through transformational periods will be critical to Aspen as we move into this new stage. ....

United States , San Diego , Jeanne Loring , Acadia Pharmaceuticals , Aspen Neuroscience Inc , Akcea Therapeutics Inc , Ionis Pharmaceuticals , Glaxosmithkline Pharmaceuticals , Aspen Neuroscience , Akcea Therapeutics , ஒன்றுபட்டது மாநிலங்களில் , சான் டியாகோ , ஜீன் லொரிங் , அகாடியா மருந்துகள் , ஆஸ்பென் நரம்பியல் இன்க் , கிளாக்சோஸ்மித்க்லைன் மருந்துகள் , ஆஸ்பென் நரம்பியல் ,